Recombinant adeno-associated virus vectors
US11981914B2 · kind B2 · utility
0Cited by
118References
20Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 25, 2023 |
| Grant date | May 14, 2024 |
| Priority date | — |
| Expiry date | Sep 25, 2043 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2750/14143
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
AAV capsid proteins comprising a modification in the amino acid sequence and virus vectors comprising the modified AAV capsid protein are described. Also described are methods of administering the virus vectors and virus capsids to a cell or to a subject in vivo.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.